HUTCHMED (China) Limited - American Depositary Shares (NQ:HCM)

14.10 +0.43 (+3.15%)

Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HUTCHMED (China) Limited - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Axsome Therapeutics Stock Clears Key Benchmark, Hits 80-Plus RS Rating ↗

September 27, 2023

A Relative Strength Rating upgrade for Axsome Therapeutics shows improving technical performance.

Via Investor's Business Daily

HUTCHMED Highlights Presentation of Results from the Phase IIIb Trial of Savolitinib at the 2023 World Conference of Lung Cancer

September 12, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in China

September 11, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

Tesla, Crinetics Pharmaceuticals And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

September 11, 2023

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

HUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric Cancer

August 28, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca ↗

August 26, 2023

China’s drug distributors are in the hunt to acquire Poland’s Neuca, a company with a 32% market share of Poland’s pharmaceutical distribution business. The consortium of China’s drug distributors may...

Via Talk Markets

Hutchmed's Candidate Achieves Main Goal In China's Rare Blood Disorder Study ↗

August 21, 2023

HUTCHMED (China) Limited's (NASDAQ: HCM) pivotal Phase 3 trial ESLIM-01 evaluating the investigational use of sovleplenib met its primary endpoint of durable response rate and all secondary endpoints...

Via Benzinga

HUTCHMED Announces that the Sovleplenib Phase III ESLIM-01 Study Met Its Primary Endpoint in Primary Immune Thrombocytopenia in China

August 20, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 07, 2023

Via Benzinga

Why Kosmos Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

August 07, 2023

Gainers Save Foods, Inc. (NASDAQ: SVFD) shares surged 76.6% to $1.13 in pre-market trading after gaining 15% on Friday.

Via Benzinga

Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 07, 2023

Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

August 07, 2023

It's time to start off the week with a breakdown of the biggest pre-market stock movers worth reading about on Monday morning!

Via InvestorPlace

Sohu.com, Cloudflare And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

August 07, 2023

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. HUTCHMED (China) Limited (NYSE: HCM) shares dipped 14.1% to...

Via Benzinga

Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 01, 2023

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.

Via Benzinga

Caterpillar, Oshkosh, AudioCodes And Other Big Stocks Moving Higher On Tuesday ↗

August 01, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling around 70 points on Tuesday. Here are some big stocks recording gains in today’s session. American Superconductor Corporation (NASDAQ: AMSC)...

Via Benzinga

HUTCHMED Reports 2023 Interim Results and Provides Business Updates

July 31, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study

July 19, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

Earnings Scheduled For July 31, 2023 ↗

July 31, 2023

Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million.

Via Benzinga

HUTCHMED Announces Changes to Board of Directors and Technical Committee

July 13, 2023

Ms Ling Yang to replace Mr Lefei Sun as Non-executive Director; Professor Solange Peters appointed as Special Advisor to the Technical Committee

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Initiates Phase I Study of its novel SHP2 inhibitor HMPL-415 for Advanced Malignant Solid Tumors in China

July 09, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED to Announce 2023 Half-Year Financial Results

June 26, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 20, 2023

Via Benzinga

HUTCHMED and Takeda Announce Publication of Phase III FRESCO-2 Results in The Lancet

June 15, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

Takeda and HUTCHMED Announce Marketing Authorization Application of Fruquintinib for Previously Treated Metastatic Colorectal Cancer Validated by the European Medicines Agency

June 15, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Highlights Presentations for Hematological Malignancy Programs at the 2023 EHA and ICML Meetings

June 09, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 30, 2023

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.

Via Benzinga

Skyline Champion, Atea Pharmaceuticals And Other Big Stocks Moving Lower On Tuesday ↗

May 30, 2023

U.S. stocks traded mixed, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

10 Stocks Reacting To April PCE: Marvell Technology Leads The Rally ↗

May 26, 2023

Via Benzinga

Takeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review

May 25, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Highlights Presentations at the 2023 ASCO Annual Meeting

May 25, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.